Click Therapeutics is well on its way to doing both – and in a sit down interview at the Informa Biotech Showcase in San ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Sanofi has said it will press ahead with regulatory filings for atopic dermatitis (AD) candidate amlitelimab after reporting ...

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...

"The addition of relacorilant to nab-paclitaxel, a trusted and effective chemotherapy, is positioned to become a new standard ...

The EVA for DHTs used by people with hip and knee osteoarthritis (PDF) recommends eight products, namely: GetUBetter; Good ...

The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in obesity, with some also earmarked for two other programmes – an ...

DMHTs sit within a broader wave of digital health technologies, helping manage a range of issues such as asthma with smart ...

J&J is predicting 2026 revenues will be between $99.5 billion and $100.5 billion, up from just over $94 billion in 2025.

Amazon has become the latest tech company to introduce an AI-powered assistant that is designed to provide health guidance ...

The European Commission has approved Otsuka's Dawnzera for the prevention of recurrent attacks in rare disease hereditary angioedema (HAE), a drug that can be self-administered by patients with weeks ...